Annual EBIT
-$30.41 M
+$57.49 M+65.40%
31 December 2022
Summary:
Catalyst Biosciences annual earnings before interest & taxes is currently -$30.41 million, with the most recent change of +$57.49 million (+65.40%) on 31 December 2022. During the last 3 years, it has risen by +$57.49 million (+65.40%).CBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.62 M
+$920.00 K+36.18%
30 September 2023
Summary:
Catalyst Biosciences quarterly earnings before interest & taxes is currently -$1.62 million, with the most recent change of +$920.00 thousand (+36.18%) on 30 September 2023.CBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$71.34 M
+$3.26 M+4.37%
30 September 2023
Summary:
Catalyst Biosciences TTM earnings before interest & taxes is currently -$71.34 million, with the most recent change of +$3.26 million (+4.37%) on 30 September 2023.CBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +65.4% | +92.0% | +18.9% |
| 5 y5 years | +46.9% | +88.4% | -24.6% |
CBIO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -283.5% | -110.1% | -467.4% |
Catalyst Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.62 M(-36.2%) | -$71.34 M(-4.4%) |
| June 2023 | - | -$2.54 M(-44.2%) | -$74.60 M(-4.1%) |
| Mar 2023 | - | -$4.56 M(-92.7%) | -$77.78 M(-11.5%) |
| Dec 2022 | -$30.41 M(-65.4%) | -$62.62 M(+1182.4%) | -$87.92 M(+92.6%) |
| Sept 2022 | - | -$4.88 M(-14.6%) | -$45.65 M(-30.8%) |
| June 2022 | - | -$5.71 M(-61.1%) | -$65.99 M(-17.7%) |
| Mar 2022 | - | -$14.70 M(-27.8%) | -$80.17 M(-8.8%) |
| Dec 2021 | -$87.89 M(+53.2%) | -$20.35 M(-19.3%) | -$87.91 M(+1.7%) |
| Sept 2021 | - | -$25.22 M(+26.7%) | -$86.40 M(+11.8%) |
| June 2021 | - | -$19.90 M(-11.3%) | -$77.28 M(+3.4%) |
| Mar 2021 | - | -$22.44 M(+19.1%) | -$74.74 M(+30.3%) |
| Dec 2020 | -$57.37 M(+0.2%) | -$18.84 M(+17.0%) | -$57.37 M(+9.2%) |
| Sept 2020 | - | -$16.10 M(-7.3%) | -$52.52 M(+5.9%) |
| June 2020 | - | -$17.36 M(+242.6%) | -$49.61 M(+6.4%) |
| Mar 2020 | - | -$5.07 M(-63.8%) | -$46.63 M(-18.6%) |
| Dec 2019 | -$57.28 M(+69.3%) | -$13.99 M(+6.0%) | -$57.28 M(+4.2%) |
| Sept 2019 | - | -$13.20 M(-8.2%) | -$54.97 M(+9.7%) |
| June 2019 | - | -$14.38 M(-8.5%) | -$50.12 M(+17.0%) |
| Mar 2019 | - | -$15.71 M(+34.5%) | -$42.86 M(+26.7%) |
| Dec 2018 | -$33.82 M(+55.0%) | -$11.68 M(+40.0%) | -$33.82 M(+20.9%) |
| Sept 2018 | - | -$8.35 M(+17.3%) | -$27.97 M(+9.7%) |
| June 2018 | - | -$7.11 M(+6.5%) | -$25.50 M(+4.8%) |
| Mar 2018 | - | -$6.68 M(+14.6%) | -$24.33 M(+11.5%) |
| Dec 2017 | -$21.82 M(+6.9%) | -$5.83 M(-0.8%) | -$21.82 M(+2.9%) |
| Sept 2017 | - | -$5.88 M(-1.1%) | -$21.21 M(+0.8%) |
| June 2017 | - | -$5.94 M(+42.5%) | -$21.05 M(+5.1%) |
| Mar 2017 | - | -$4.17 M(-20.1%) | -$20.02 M(-2.0%) |
| Dec 2016 | -$20.42 M(+53.7%) | -$5.22 M(-8.6%) | -$20.42 M(+0.4%) |
| Sept 2016 | - | -$5.71 M(+16.2%) | -$20.33 M(+11.5%) |
| June 2016 | - | -$4.92 M(+7.5%) | -$18.23 M(+3.3%) |
| Mar 2016 | - | -$4.57 M(-10.9%) | -$17.65 M(-10.9%) |
| Dec 2015 | -$13.28 M(-54.4%) | -$5.13 M(+42.0%) | -$19.81 M(+2.7%) |
| Sept 2015 | - | -$3.61 M(-16.7%) | -$19.29 M(-6.0%) |
| June 2015 | - | -$4.34 M(-35.6%) | -$20.52 M(-15.4%) |
| Mar 2015 | - | -$6.73 M(+46.0%) | -$24.27 M(-16.6%) |
| Dec 2014 | -$29.12 M(-37.6%) | -$4.61 M(-4.9%) | -$29.12 M(-23.1%) |
| Sept 2014 | - | -$4.84 M(-40.1%) | -$37.86 M(-17.5%) |
| June 2014 | - | -$8.09 M(-30.2%) | -$45.90 M(-8.5%) |
| Mar 2014 | - | -$11.58 M(-13.3%) | -$50.17 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$46.65 M(+565.1%) | -$13.35 M(+3.6%) | -$46.65 M(-5.3%) |
| Sept 2013 | - | -$12.89 M(+4.3%) | -$49.25 M(+11.4%) |
| June 2013 | - | -$12.36 M(+53.5%) | -$44.22 M(+154.9%) |
| Mar 2013 | - | -$8.05 M(-49.5%) | -$17.35 M(+147.4%) |
| Dec 2012 | -$7.01 M(-16.5%) | -$15.95 M(+103.0%) | -$7.01 M(+742.9%) |
| Sept 2012 | - | -$7.86 M(-154.1%) | -$832.00 K(-58.1%) |
| June 2012 | - | $14.51 M(+535.2%) | -$1.99 M(-89.6%) |
| Mar 2012 | - | $2.29 M(-123.4%) | -$19.07 M(+110.6%) |
| Dec 2011 | -$8.40 M(-157.6%) | -$9.77 M(+8.4%) | -$9.06 M(+3157.6%) |
| Sept 2011 | - | -$9.02 M(+250.6%) | -$278.00 K(-102.4%) |
| June 2011 | - | -$2.57 M(-120.9%) | $11.51 M(-40.7%) |
| Mar 2011 | - | $12.30 M(-1337.6%) | $19.42 M(+33.2%) |
| Dec 2010 | $14.58 M(-137.1%) | -$994.00 K(-135.8%) | $14.58 M(-235.1%) |
| Sept 2010 | - | $2.78 M(-47.9%) | -$10.79 M(-11.5%) |
| June 2010 | - | $5.33 M(-28.6%) | -$12.19 M(-55.0%) |
| Mar 2010 | - | $7.46 M(-128.3%) | -$27.12 M(-30.9%) |
| Dec 2009 | -$39.27 M(+54.6%) | -$26.36 M(-2014.7%) | -$39.27 M(+145.1%) |
| Sept 2009 | - | $1.38 M(-114.3%) | -$16.02 M(-37.3%) |
| June 2009 | - | -$9.60 M(+104.6%) | -$25.56 M(+9.2%) |
| Mar 2009 | - | -$4.69 M(+50.6%) | -$23.40 M(-7.9%) |
| Dec 2008 | -$25.41 M(-20.0%) | -$3.11 M(-61.8%) | -$25.41 M(-17.9%) |
| Sept 2008 | - | -$8.16 M(+9.8%) | -$30.95 M(-0.8%) |
| June 2008 | - | -$7.43 M(+10.9%) | -$31.19 M(-5.0%) |
| Mar 2008 | - | -$6.70 M(-22.6%) | -$32.83 M(+3.3%) |
| Dec 2007 | -$31.77 M(+7770.1%) | -$8.65 M(+3.0%) | -$31.77 M(+351.3%) |
| Sept 2007 | - | -$8.40 M(-7.4%) | -$7.04 M(+64.2%) |
| June 2007 | - | -$9.07 M(+60.8%) | -$4.29 M(+704.7%) |
| Mar 2007 | - | -$5.64 M(-135.1%) | -$533.00 K(+32.0%) |
| Dec 2006 | -$403.70 K(-98.7%) | $16.08 M(-384.5%) | -$403.70 K(-98.3%) |
| Sept 2006 | - | -$5.65 M(+6.3%) | -$23.26 M(-6.1%) |
| June 2006 | - | -$5.32 M(-3.6%) | -$24.77 M(-10.9%) |
| Mar 2006 | - | -$5.51 M(-18.6%) | -$27.80 M(-7.2%) |
| Dec 2005 | -$29.94 M(+22.7%) | -$6.78 M(-5.5%) | -$29.94 M(+29.2%) |
| Sept 2005 | - | -$7.17 M(-14.0%) | -$23.17 M(+44.8%) |
| June 2005 | - | -$8.34 M(+8.9%) | -$16.00 M(+108.9%) |
| Mar 2005 | - | -$7.66 M | -$7.66 M |
| Dec 2004 | -$24.39 M(+21.6%) | - | - |
| Dec 2003 | -$20.06 M(-4.5%) | - | - |
| Dec 2002 | -$21.00 M(+140.0%) | - | - |
| Dec 2001 | -$8.75 M | - | - |
FAQ
- What is Catalyst Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Catalyst Biosciences?
- What is Catalyst Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Catalyst Biosciences?
What is Catalyst Biosciences annual earnings before interest & taxes?
The current annual EBIT of CBIO is -$30.41 M
What is the all time high annual EBIT for Catalyst Biosciences?
Catalyst Biosciences all-time high annual earnings before interest & taxes is $16.57 M
What is Catalyst Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of CBIO is -$1.62 M
What is the all time high quarterly EBIT for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly earnings before interest & taxes is $16.08 M
What is Catalyst Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of CBIO is -$71.34 M
What is the all time high TTM EBIT for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM earnings before interest & taxes is $19.42 M